Screening for gestational diabetes mellitus Screening for gestational diabetes mellitus Screening for gestational diabetes mellitus Hillier T, Vesco K, Whitlock E, Pettitt D, Pedula K, Beil T Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Hillier T, Vesco K, Whitlock E, Pettitt D, Pedula K, Beil T. Screening for gestational diabetes (...) mellitus. Rockville: Agency for Healthcare Research and Quality (AHRQ). Evidence Synthesis No 60. 2008 Authors' objectives This review identifies and evaluates new evidence since the prior review on the risks and benefits of GDM screening at 24 weeks or later; it also newly reviews all of the available evidence pertaining to GDM screening prior to 24 weeks. Authors' conclusions We found limited evidence to evaluate early screening for GDM prior to 24 weeks gestation, the purpose of which would

Screening for gestational diabetes Screening for gestational diabetes Screening for gestational diabetes Liufu V, Mundy L, Hiller JE Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Liufu V, Mundy L, Hiller JE. Screening for gestational diabetes. Adelaide: Adelaide Health Technology Assessment (AHTA). Prioritising Summary. Volume 21. 2008 (...) Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Diabetes, Gestationals; Mass Screening; Pregnancy Language Published English Country of organisation Australia English summary An English language summary is available. Address for correspondence Adelaide Health Technology Assessment, University of Adelaide, Discipline of Public Health, School of Population Health and Clinical Practice, Mail Drop DX650545, SA 5005 Adelaide Australia Email: tracy.merlin@adelaide.edu.au

Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes Nicholson WK, Wilson LM, Witkop CT, Baptiste-Roberts K, Bennett WL, Bolen S, Barone BB, Golden SH, Gary TL, Neale DM, Bass EB Citation Nicholson WK, Wilson LM, Witkop CT, Baptiste-Roberts K (...) , Bennett WL, Bolen S, Barone BB, Golden SH, Gary TL, Neale DM, Bass EB. Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes. Rockville: Agency for Healthcare Research and Quality (AHRQ). Evidence Report/Technology Assessment No. 162. 2008 Authors' objectives

We focused on four questions: (1) What are the risks and benefits of an oral diabetes agent (i.e., glyburide), as compared to all types of insulin, for gestational diabetes? (2) What

No summary available

The role of exercise in preventing and treating gestational diabetes: a comprehensive review and recommendations for future research The role of exercise in preventing and treating gestational diabetes: a comprehensive review and recommendations for future research The role of exercise in preventing and treating gestational diabetes: a comprehensive review and recommendations for future research DiNallo J M, Downs D S CRD summary The authors concluded that exercise may have positive (...) and protective effects for the treatment and prevention of GDM (gestational diabetes mellitus). In view of poor reporting in the review, the small number of controlled studies, failure to assess or address heterogeneity between the studies and failure to systematically assess study quality, it is impossible to determine the reliability of the conclusions. Authors' objectives To assess the effects of exercise for treating, preventing or delaying GDM. Searching PsycLit, MEDLINE, Dissertation Abstracts Online

Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes Nicholson W K, Wilson L M, Witkop C T, Baptiste-Roberts K, Bennett W L, Bolen S, Barone B B, Golden S H, Gary T L, Neale D M, Bass E B CRD summary This review assessed treatment, delivery (...) options and subsequent testing for type-2 diabetes for women with gestational diabetes. The authors concluded that there was insufficient evidence to recommend insulin alternatives or to formulate delivery guidelines and the 75-gm OGTT test should be retained for post-partum testing. This was a well-conducted review. The conclusions reflected the limited evidence accurately and are likely to be reliable. Authors' objectives Identified objectives were: to determine the efficacy and safety of oral

Screening for gestational diabetes mellitus Screening for gestational diabetes mellitus Screening for gestational diabetes mellitus Hillier T A, Vesco K K, Whitlock E P, Pettitt D J, Pedula K L, Beil T L CRD summary The authors of this well-conducted review concluded that the limited evidence about early (<24 weeks) gestational diabetes mellitus (GDM) indicates a need for more research. The conclusion, which was based on one recent good-quality study in which screening identified women (...) with mild GDM after 24 weeks' gestation and improved maternal and neonatal outcomes, is likely to be reliable. Authors' objectives To evaluate the benefits and harms of screening for gestational diabetes mellitus (GDM). Searching MEDLINE, the Cochrane CENTRAL Register, the Cochrane Database of Systematic Reviews, DARE, HTA and the National Institute for Health and Clinical Excellence were searched from 2000 to September 2006l the search terms were reported. In addition, the reference lists from

Review: little evidence exists on the benefits and harms of screening for and treating gestational diabetes Review: little evidence exists on the benefits and harms of screening for and treating gestational diabetes | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search (...) for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: little evidence exists on the benefits and harms of screening for and treating gestational diabetes Article Text Therapeutics Review: little evidence exists on the benefits and harms of screening for and treating gestational diabetes Statistics from Altmetric.com No Altmetric data available

Gestational Diabetes

Metformin (alone or with insulin) was as effective as insulin for preventing perinatal complications in gestational diabetes Metformin (alone or with insulin) was as effective as insulin for preventing perinatal complications in gestational diabetes | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your (...) user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Metformin (alone or with insulin) was as effective as insulin for preventing perinatal complications in gestational diabetes Article Text Therapeutics Metformin (alone or with insulin) was as effective as insulin for preventing perinatal complications

Metformin versus insulin for the treatment of gestational diabetes. 18463376 2008 05 08 2008 05 14 2013 11 21 1533-4406 358 19 2008 May 08 The New England journal of medicine N. Engl. J. Med. Metformin versus insulin for the treatment of gestational diabetes. 2003-15 10.1056/NEJMoa0707193 Metformin is a logical treatment for women with gestational diabetes mellitus, but randomized trials to assess the efficacy and safety of its use for this condition are lacking. We randomly assigned 751 women (...) with gestational diabetes mellitus at 20 to 33 weeks of gestation to open treatment with metformin (with supplemental insulin if required) or insulin. The primary outcome was a composite of neonatal hypoglycemia, respiratory distress, need for phototherapy, birth trauma, 5-minute Apgar score less than 7, or prematurity. The trial was designed to rule out a 33% increase (from 30% to 40%) in this composite outcome in infants of women treated with metformin as compared with those treated with insulin. Secondary

Efficacy, safety and lack of immunogenicity of insulin aspart compared with regular human insulin for women with gestational diabetes mellitus AIM: The efficacy and safety of insulin aspart (IAsp), a rapid-acting human insulin analogue, were compared with regular human insulin (HI) as the bolus component of basal-bolus therapy for subjects with gestational diabetes mellitus (GDM). METHODS: In a randomized, parallel-group, open-labelled trial, 27 women with GDM (age 30.7 +/- 6.3 years, HbA(1c

WITHDRAWN: Dietary regulation for 'gestational diabetes'. BACKGROUND: Impaired glucose metabolism in pregnancy may be associated with adverse pregnancy outcomes. Primary dietary therapy is used in the management of diabetes, including gestational diabetes. OBJECTIVES: The objective of this review was to assess the effects of primary dietary therapy in women identified as having gestational diabetes on fetal growth and neonatal outcomes. SEARCH STRATEGY: I searched the Cochrane Pregnancy

Efficacy and cost of postpartum screening strategies for diabetes among women with histories of gestational diabetes mellitus Efficacy and cost of postpartum screening strategies for diabetes among women with histories of gestational diabetes mellitus Efficacy and cost of postpartum screening strategies for diabetes among women with histories of gestational diabetes mellitus Kim C, Herman W H, Vijan S Record Status This is a critical abstract of an economic evaluation that meets the criteria (...) . Type of economic evaluation Cost-effectiveness analysis Study objective To compare the cost and time to diagnosis associated with several screening strategies for diabetes in women with histories of gestational diabetes mellitus. Interventions The study compared different screening strategies after the 6-week postpartum oral glucose tolerance test (OGTT). The strategies included: a 2-hour 75-g OGTT annually, every 2 years or every 3 years; fasting plasma glucose (FPG) annually, every 2 years

Screening and active management reduced perinatal complications more than routine care in gestational diabetes Screening and active management reduced perinatal complications more than routine care in gestational diabetes | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password (...) ? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Screening and active management reduced perinatal complications more than routine care in gestational diabetes Article Text Therapeutics Screening and active management reduced perinatal complications more than routine care in gestational diabetes Free Joel G Ray , MD Statistics from

Screening for gestational diabetes mellitus: a decision and cost-effectiveness analysis of four screening strategies Screening for gestational diabetes mellitus: a decision and cost-effectiveness analysis of four screening strategies Screening for gestational diabetes mellitus: a decision and cost-effectiveness analysis of four screening strategies Nicholson W K, Fleisher L A, Fox H E, Powe N R Record Status This is a critical abstract of an economic evaluation that meets the criteria (...) for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Three screening strategies for the detection of gestational diabetes mellitus (GDM) were examined: the sequential strategy, which consisted of an initial 50-g glucose challenge test followed, in those who test positive, by a 100-g glucose tolerance test (GTT); the 75-g GTT strategy

Screening and treatment of gestational diabetes melliitus in pregnant women

Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. 15951574 2005 06 16 2005 06 22 2011 11 17 1533-4406 352 24 2005 Jun 16 The New England journal of medicine N. Engl. J. Med. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. 2477-86 We conducted a randomized clinical trial to determine whether treatment of women with gestational diabetes mellitus reduced the risk of perinatal complications. We randomly assigned women between 24 and 34 weeks (...) ' gestation who had gestational diabetes to receive dietary advice, blood glucose monitoring, and insulin therapy as needed (the intervention group) or routine care. Primary outcomes included serious perinatal complications (defined as death, shoulder dystocia, bone fracture, and nerve palsy), admission to the neonatal nursery, jaundice requiring phototherapy, induction of labor, cesarean birth, and maternal anxiety, depression, and health status. The rate of serious perinatal complications

Effect of varying threshold and selective versus universal strategies on the cost in gestational diabetes mellitus Effect of varying threshold and selective versus universal strategies on the cost in gestational diabetes mellitus Effect of varying threshold and selective versus universal strategies on the cost in gestational diabetes mellitus Larijani B, Hossein-Nezhad A, Vassigh A R Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS (...) EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The authors assessed the screening method best-suited for gestational diabetes mellitus (GDM) in Iran. The screening and diagnostic strategies compared were selective versus universal strategies with thresholds of 130 and 140 mg/dL. A two-step approach for screening and diagnosis was used

Screening for gestational diabetes mellitus Screening for gestational diabetes mellitus Screening for gestational diabetes mellitus Brody S, Harris R P, Whitener B L, Krasnov C, Lux L J, Sutton S F, Lohr K N Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Brody S, Harris R P, Whitener B L, Krasnov C, Lux L J, Sutton S F, Lohr K N (...) . Screening for gestational diabetes mellitus. Rockville: Agency for Healthcare Research and Quality (AHRQ). Preventive Services Task Force Systematic Evidence Review No. 26. 2003 Authors' objectives To systematically review the evidence about the benefits and harms of screening pregnant women for gestational diabetes mellitus (GDM). Authors' conclusions The evidence of screening for GDM is insufficient to determine the extent to which screening has an important impact on maternal and neonatal health